Skip to main content
Equibles

Caitong International Asset Management Co., Ltd

Position in ADCT — ADC Therapeutics SA

CIK 1963355 HONG KONG, K3
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$7,541
+$7,534 QoQ
Shares Held
7,048
+352300.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 113 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Caitong International Asset Management Co., Ltd holds $770,442 across 41 Drug Manufacturers - Specialty & Generic names. ADCT ranks #14 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BCRX
Biocryst Pharmaceuticals Inc
 20,925 $209,250
2 RDY
Dr Reddys Laboratories Ltd
 11,751 $170,271
3 TAK
Takeda Pharmaceutical Co Ltd
 6,656 $106,695
4 TEVA
Teva Pharmaceutical Industries Ltd
 2,099 $71,114
5 SUPN
Supernus Pharmaceuticals, Inc.
 973 $45,254
6 ETON
Eton Pharmaceuticals, Inc.
 842 $30,480
7 LQDA
Liquidia Corp
 331 $26,390
8 XERS
Xeris Biopharma Holdings, Inc.
 2,746 $21,748

All Filings in ADCT

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,541 7,048
2026-03-31 $7 2